Open Beta
MetriLume

US marketsBDPT

SEC-sourced researchBeta

BDPT

BIOADAPTIVES, INC.

Company comparison ↗

Data passport

CIK
0001575142
Exchange
OTC
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Nov 16, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 12,669.0000 USD; December 2025: 18,278.0000 USD18.3K USD0 USD0December 2024December 2025
BDPT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202412,669.0000Apr 14, 2026
December 202518,278.0000Apr 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202518,278.0000-1,557,898.0000-516,025.0000225,901.00002,355,957.0000Apr 14, 2026
December 202412,669.0000-899,161.0000-249,517.0000261,885.00001,725,803.0000Apr 14, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

39/100
Profitability0
Growth94
Balance sheet0
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$18.28KJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Previous period revenueRevenues$12.67KJan 1, 2024 – Dec 31, 2024Apr 14, 202610-K
Net incomeNetIncomeLoss-$1.56MJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$516.03KJan 1, 2025 – Dec 31, 2025Apr 14, 202610-K
Total assetsAssets$225.9KDec 31, 2025Apr 14, 202610-K
Total liabilitiesLiabilities$2.36MDec 31, 2025Apr 14, 202610-K

New filings

Explore methodology ↗